IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 228 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $69,456 | -66.4% | 15,265 | +132.9% | 0.00% | – |
| Q1 2021 | $207,000 | +0.5% | 6,554 | +48.0% | 0.00% | – |
| Q4 2020 | $206,000 | +8.4% | 4,429 | -77.9% | 0.00% | -100.0% |
| Q1 2019 | $190,000 | +7.3% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $177,000 | -21.3% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $225,000 | -10.7% | 20,000 | +1.8% | 0.00% | 0.0% |
| Q2 2018 | $252,000 | +29.9% | 19,650 | +70.8% | 0.00% | 0.0% |
| Q1 2018 | $194,000 | +2671.4% | 11,505 | +1050.5% | 0.00% | – |
| Q2 2017 | $7,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,222,701 | $25,005,000 | 8.92% |
| Broadfin Capital, LLC | 4,894,361 | $55,062,000 | 8.10% |
| GREAT POINT PARTNERS LLC | 3,496,340 | $39,334,000 | 6.13% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $24,619,000 | 4.51% |
| Prosight Management, LP | 715,317 | $8,047,000 | 4.49% |
| Avoro Capital Advisors LLC | 8,662,720 | $97,456,000 | 4.48% |
| QVT Financial LP | 821,361 | $8,748,000 | 2.26% |
| Perceptive Advisors | 7,290,199 | $82,014,000 | 2.19% |
| Rhenman & Partners Asset Management AB | 1,290,495 | $14,518,000 | 1.46% |
| EMORY UNIVERSITY | 185,915 | $2,092,000 | 1.37% |